🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/07/2007 | 26,65 | 26,95 | 25,83 | 25,90 | -3,22% | 4,21% | 143.041 |
| 13/07/2007 | 26,91 | 27,14 | 26,58 | 26,76 | -0,14% | 2,09% | 148.010 |
| 12/07/2007 | 26,43 | 26,91 | 25,75 | 26,80 | +2,29% | 4,39% | 163.319 |
| 11/07/2007 | 25,98 | 26,24 | 25,64 | 26,20 | +1,30% | 2,31% | 122.736 |
| 10/07/2007 | 26,43 | 26,72 | 25,64 | 25,86 | -3,49% | 4,11% | 167.861 |
| 09/07/2007 | 26,99 | 27,14 | 26,35 | 26,80 | -1,11% | 2,91% | 173.071 |
| 06/07/2007 | 26,72 | 27,32 | 26,54 | 27,10 | +0,98% | 2,94% | 123.591 |
| 05/07/2007 | 26,84 | 26,95 | 26,58 | 26,84 | -0,14% | 1,39% | 153.461 |
| 03/07/2007 | 26,54 | 26,95 | 26,28 | 26,87 | +1,13% | 2,54% | 71.574 |
| 02/07/2007 | 25,75 | 26,72 | 25,68 | 26,58 | +3,20% | 4,07% | 313.574 |
| 29/06/2007 | 26,54 | 26,72 | 25,71 | 25,75 | -2,82% | 3,81% | 193.776 |
| 28/06/2007 | 26,39 | 26,69 | 26,39 | 26,50 | +0,43% | 1,13% | 129.549 |
| 27/06/2007 | 25,23 | 26,46 | 25,08 | 26,39 | +3,37% | 5,49% | 182.368 |
| 26/06/2007 | 25,83 | 26,16 | 25,30 | 25,53 | -0,58% | 3,33% | 94.924 |
| 25/06/2007 | 25,79 | 26,76 | 25,49 | 25,68 | -1,15% | 4,93% | 202.619 |
| 22/06/2007 | 26,65 | 26,84 | 25,68 | 25,98 | -2,94% | 4,35% | 2.263.356 |
| 21/06/2007 | 26,87 | 27,59 | 26,58 | 26,76 | +0,00% | 3,76% | 166.712 |
| 20/06/2007 | 27,06 | 27,25 | 26,50 | 26,76 | -0,69% | 2,77% | 220.493 |
| 19/06/2007 | 26,31 | 27,06 | 26,20 | 26,95 | +2,86% | 3,27% | 390.411 |
| 18/06/2007 | 25,83 | 26,58 | 25,64 | 26,20 | +2,04% | 3,62% | 566.874 |
| 15/06/2007 | 25,08 | 26,13 | 24,97 | 25,68 | +3,16% | 4,63% | 669.119 |
| 14/06/2007 | 24,44 | 25,15 | 24,18 | 24,89 | +1,68% | 3,98% | 117.981 |
| 13/06/2007 | 24,18 | 25,19 | 24,10 | 24,48 | +1,40% | 4,49% | 293.349 |
| 12/06/2007 | 24,89 | 25,08 | 24,14 | 24,14 | -2,72% | 3,76% | 317.421 |
| 11/06/2007 | 25,68 | 25,68 | 24,74 | 24,82 | +0,91% | 3,64% | 187.230 |
| 08/06/2007 | 24,25 | 24,85 | 24,07 | 24,59 | +1,08% | 3,24% | 162.517 |
| 07/06/2007 | 24,52 | 24,59 | 24,10 | 24,33 | -1,52% | 1,98% | 169.597 |
| 06/06/2007 | 24,07 | 24,89 | 24,03 | 24,70 | +1,54% | 3,58% | 150.842 |
| 05/06/2007 | 24,48 | 24,67 | 24,14 | 24,33 | -0,76% | 2,14% | 176.757 |
| 04/06/2007 | 24,40 | 24,59 | 24,40 | 24,52 | +0,15% | 0,77% | 115.630 |